Studies related to Fever and Vitamin D

Randomized Trial Of Vitamin D Supplementation To Prevent Seasonal Influenza A In Schoolchildren

Effect None
Values Nonspecific febrile disease. Placebo: 5/167 (3.0) Vitamin D: 4/167 (2.4)
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 334
Sex Both Genders
Age Range 1-6, 7-12, 13-17
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 334 school children were given 1200 IU of vitamin D or placebo daily for 4 months from December to the end of March.

96 participants dropped out of the study and weren't analyzed. The primary outcome was the incidence of influenza A, and the vitamin D group had a significantly lower rate. The vitamin D group had a nonsignificantly higher rate of influenza B, asthma, and gastroenteritis, the same rate of influenza-like illness, nonspecific febrile disease, and pneumonia.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.